Lupin Ltd. et al. vs. SENJU PHARMACEUTICAL CO., LTD. et al.
Explore the PTAB proceeding IPR2015-01097 filed by Lupin Ltd. et al. on 2015-04-23. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2015-01097
Filing Date
2015-04-23
Accorded Filing Date
2015-04-23
Institution Decision Date
2015-10-27
Last Modified Date
2022-10-10
Proceeding Type
IPR
Termination Date
2016-09-12
Trial Status
Final Written Decision
Parties & Counsel
Petitioner
Lupin Ltd. et al.
Represented By
Yellin, Deborahet alPatent Owner / Respondent
SENJU PHARMACEUTICAL CO., LTD. et al.
Represented By
Diner, Bryanet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Final Written Decision
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 40268 | Michael Huppert | +1 202-721-8200 |
| 41023 | Paul Fournier | +1 202-721-8257 |
| 41471 | Jeffrey Filipek | +1 202-721-8200 |
| 44142 | William Hahm | +1 202-721-8200 |
| 44765 | Mark Hissong | +1 202-721-8237 |
| 45336 | David Ovedovitz | +1 202-721-8200 |
| 45794 | Mark Pratt | +1 202-721-8200 |
| 52430 | Kenneth Fields | +1 202-721-8200 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 10 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 8,754,131 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,871,813 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 9,144,609 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,927,606 B1 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 9,561,277 B2 | US Continuation / Sibling | View Official Patent → |
| ๐ฏ๐ต Japan | JP 2003012427 | Japan Counterpart | View Official Patent → |
| ๐ PCT International (WIPO) | WO 2004064828 A1 | PCT World Application | View Official Patent → |
| ๐บ๐ธ United States | US 8,129,431 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,497,304 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 8,669,290 B2 | US Continuation / Sibling | View Official Patent → |
InnoPharma Licensing, Inc. et al. v. SENJU PHARMACEUTICAL CO., LTD. et al.
InnoPharma Licensing, Inc. v. SENJU PHARMACEUTICAL CO., LTD. et al.
InnoPharma Licensing, Inc. et al. v. SENJU PHARMACEUTICAL CO., LTD. et al.
Lupin Ltd. et al. v. SENJU PHARMACEUTICAL CO., LTD. et al.
Lupin Ltd. et al. v. SENJU PHARMACEUTICAL CO., LTD. et al.
Lupin Ltd. et al. v. Senju Pharmaceutical Co., Ltd. et al.
Lupin Ltd. et al. v. SENJU PHARMACEUTICAL CO., LTD. et al.
InnoPharma, Licensing, Inc. et al. v. Senju Pharmaceutical Co., Ltd. et al.
InnoPharma Licensing, Inc. et al. v. SENJU PHARMACEUTICAL CO., LTD. et al.